Indian Lenvatinib Exporters: Complete Supplier Ranking with Market Share — 127 Manufacturers (2026) — TransData Nexus

Q: Who is the largest lenvatinib supplier from India?

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the largest lenvatinib exporter from India with a 35.0% market share and export value of $746.3K.

Q: How many lenvatinib suppliers are there in India?

There are 127 active lenvatinib exporters in India, collectively shipping $2.1M worth of lenvatinib across 863 shipments according to Indian Customs (DGFT) records.

Q: What is the market share of top lenvatinib suppliers from India?

The top 5 lenvatinib suppliers from India — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SANDOZ PRIVATE LIMITED, PROSPERA LIFE SCIENCES PRIVATE LIMITED, BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED, GNH INDIA PHARMACEUTICALS LIMITED — together control 63.0% of total lenvatinib export value from India.

Suresh Sormare

Lenvatinib

India Pharmaceutical Trade Intelligence

$2.1M127 Suppliers74 CountriesHS 30049099

ExportsIndia → BRAZIL38.3%India → SLOVENIA14.6%

ImportsUNITED STATES → India$110.3M JAPAN → India$1.2M

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: LEK PHARMACEUTICALS

Lenvatinib Suppliers from India (2026) — 127 Exporters, $2.1M Market | TransData Nexus | TransData Nexus

Who Exports Lenvatinib from India — 127 Suppliers Behind a $2.1M Market

India's lenvatinib export market is supplied by 127 active exporters who collectively shipped $2.1M across 863 shipments. SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with a 35.0% market share, followed by SANDOZ PRIVATE LIMITED and PROSPERA LIFE SCIENCES PRIVATE LIMITED. The top 5 suppliers together control 63.0% of total export value, reflecting a concentrated market structure.

Source: Indian Customs (DGFT)·Published April 2026

India's Top Lenvatinib Suppliers & Exporters — 127 manufacturers, $2.1M export market, top destinations and formulations — Lenvatinib supplier data — 127 exporters · $2.1M market · 863 shipmentsTransData Nexus · Indian Customs Data

Top Lenvatinib Exporters from India — Ranked by Export Value

SUN PHARMACEUTICAL INDUSTRIES LIMITED is the leading lenvatinib exporter from India, holding a 35.0% share of the $2.1M market across 863 shipments from 127 exporters. The top 5 suppliers — SUN PHARMACEUTICAL INDUSTRIES LIMITED, SANDOZ PRIVATE LIMITED, PROSPERA LIFE SCIENCES PRIVATE LIMITED, BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED, GNH INDIA PHARMACEUTICALS LIMITED — collectively control 63.0% of total export value, indicating a moderately concentrated market. Individual shares are: SUN PHARMACEUTICAL INDUSTRIES LIMITED (35.0%), SANDOZ PRIVATE LIMITED (14.8%), PROSPERA LIFE SCIENCES PRIVATE LIMITED (5.4%), BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED (4.6%), GNH INDIA PHARMACEUTICALS LIMITED (3.1%).

Top Lenvatinib Exporters from India

Ranked by export value · 127 active suppliers · Indian Customs (DGFT) data

Apr 2026

Top Lenvatinib Exporters from India — Ranked by Export Value. 127 active suppliers with export value, shipments, countries and formulations data compiled from Indian Customs records by TransData Nexus.
#	Supplier & Formulations	Value	Ships.	Ctry.	Share

Supplier Certification & Compliance Matrix

FDA, WHO-GMP, and EU GMP status for top Lenvatinib exporters

Certification and compliance status for top Lenvatinib suppliers from India
Supplier	US FDA	WHO-GMP	EU GMP	ANDAs	Notes
Sun Pharmaceutical Industries Limited	Approved	Yes	Yes	Multiple	Sun Pharmaceutical Industries Limited is a leading global pharmaceutical company
BDR Pharmaceuticals International Private Limited	Not Listed	Yes	No	Not Available	BDR Pharmaceuticals International Private Limited holds WHO-GMP certification bu
Sandoz Private Limited	Approved	Yes	Yes	Multiple	Sandoz Private Limited is a globally recognized pharmaceutical company with mult
GNH India Pharmaceuticals Limited	Not Listed	Yes	No	Not Available	GNH India Pharmaceuticals Limited holds WHO-GMP certification but is not listed
Prospera Life Sciences Private Limited	Not Listed	Yes	No	Not Available	Prospera Life Sciences Private Limited holds WHO-GMP certification but is not li
Kardi Trading Private Limited	Not Listed	Yes	No	Not Available	Kardi Trading Private Limited holds WHO-GMP certification but is not listed with
Kings Global Biotech Limited	Not Listed	Yes	No	Not Available	Kings Global Biotech Limited holds WHO-GMP certification but is not listed with
Speciality Medicines Limited	Not Listed	Yes	No	Not Available	Speciality Medicines Limited holds WHO-GMP certification but is not listed with
Pharma Choice LLP	Not Listed	Yes	No	Not Available	Pharma Choice LLP holds WHO-GMP certification but is not listed with the FDA.
Heet Healthcare Private Limited	Not Listed	Yes	No	Not Available	Heet Healthcare Private Limited holds WHO-GMP certification but is not listed wi

TransData Nexus reviewed the regulatory standing of 10 leading Lenvatinib exporters from India. 2 hold US FDA facility approvals, 10 maintain WHO-GMP certification, and 2 are EU GMP compliant. For regulated markets (US, EU, Australia), prioritise suppliers with active FDA or EU GMP approvals. For semi-regulated markets (Africa, ASEAN, Latin America), WHO-GMP certification is the minimum recommended standard.

Certification status compiled from publicly available regulatory databases including FDA Orange Book, WHO Prequalification database, and EMA GMP registry. Buyers should independently verify compliance status with the relevant regulatory authority before placing orders.

TransData Nexus Research · Mar 2026

Manufacturing Hub Analysis — Vendor Proximity

India's pharmaceutical clusters relevant to Lenvatinib sourcing

1Hyderabad — Bulk Drug Capital

Hyderabad, often referred to as the "Bulk Drug Capital of India," is renowned for its extensive production of Active Pharmaceutical Ingredients (APIs). The city hosts Genome Valley, India's first biotech cluster, and is home to over 800 pharmaceutical companies, including industry leaders such as Dr. Reddy’s Laboratories and Aurobindo Pharma. This robust infrastructure supports advanced research and development, particularly in APIs, vaccines, biologics, and biosimilars.

2Ahmedabad-Vadodara — Formulations Hub

The Ahmedabad-Vadodara corridor in Gujarat is a significant hub for pharmaceutical formulations. Gujarat contributes nearly 28% of India's pharmaceutical production and houses major companies like Zydus Cadila, Intas Pharmaceuticals, and Torrent Pharmaceuticals. The region's well-developed infrastructure, including ports and transportation networks, facilitates efficient manufacturing and distribution of pharmaceutical products.

3Mumbai-Thane-Raigad — Export Gateway

The Mumbai-Thane-Raigad belt in Maharashtra serves as a crucial export gateway for pharmaceuticals. With 929 pharmaceutical units, Maharashtra is a leading contributor to India's pharmaceutical industry. The region's proximity to major ports enhances its capacity for international trade, making it a strategic location for companies aiming to export products like Lenvatinib to global markets.

Recent M&A, Collaborations & Capacity Expansions

Industry developments among top Lenvatinib exporters from India

March 2023

M&A

SUN PHARMACEUTICAL INDUSTRIES LIMITED — Sun Pharma acquires Concert Pharmaceuticals for $355 million

Sun Pharma completed the acquisition of Concert Pharmaceuticals, adding deuruxolitinib, a late-stage oral JAK inhibitor for alopecia areata, to its global dermatology portfolio. IMPACT: This acquisition enhances Sun Pharma's specialty product offerings, potentially increasing its market share and resources for Lenvatinib exports.

Impact: This acquisition enhances Sun Pharma's specialty product offerings, potentially increasing its market share and resources for Lenvatinib exports.

April 2025

Capacity Expansion

BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED — BDR Pharma plans $100 million US expansion with manufacturing buyouts

BDR Pharmaceuticals announced plans to invest $100 million in acquiring manufacturing facilities in the US to broaden its presence and cater to local demand. IMPACT: This expansion may enhance BDR's production capabilities, potentially increasing its capacity for Lenvatinib exports.

Impact: This expansion may enhance BDR's production capabilities, potentially increasing its capacity for Lenvatinib exports.

Common Questions — Lenvatinib Suppliers from India

Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus

Q Which lenvatinib supplier from India is the most reliable for bulk orders?

Based on shipment frequency and export consistency, SUN PHARMACEUTICAL INDUSTRIES LIMITED leads with 5 recorded shipments worth $746.3K. SANDOZ PRIVATE LIMITED (41 shipments) and PROSPERA LIFE SCIENCES PRIVATE LIMITED (42 shipments) are also established high-volume exporters.

Q How many lenvatinib manufacturers are there in India?

India has 127 active lenvatinib exporters with a combined export market of $2.1M across 863 shipments to 74 countries. The top 5 suppliers hold 63.0% of total export value.

Q What certifications should I verify?

Verify: WHO-GMP certification (most markets), US FDA approval (United States), EU GMP certificate (EU/EEA), and Free Sale Certificate from CDSCO. Always request a Certificate of Analysis (CoA) and Certificate of Origin (CoO).

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Lenvatinib

Lenvatinib

Who Exports Lenvatinib from India — 127 Suppliers Behind a $2.1M Market

Top Lenvatinib Exporters from India — Ranked by Export Value

Top Lenvatinib Exporters from India

Related Analysis

Need Details?

Supplier Certification & Compliance Matrix

Manufacturing Hub Analysis — Vendor Proximity

1Hyderabad — Bulk Drug Capital

2Ahmedabad-Vadodara — Formulations Hub

3Mumbai-Thane-Raigad — Export Gateway

Recent M&A, Collaborations & Capacity Expansions

SUN PHARMACEUTICAL INDUSTRIES LIMITED — Sun Pharma acquires Concert Pharmaceuticals for $355 million

BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED — BDR Pharma plans $100 million US expansion with manufacturing buyouts

Common Questions — Lenvatinib Suppliers from India

Q Which lenvatinib supplier from India is the most reliable for bulk orders?

Q How many lenvatinib manufacturers are there in India?

Q What certifications should I verify?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

4Baddi-Nalagarh — Tax Incentive Zone

5Sourcing Recommendations

SUN PHARMACEUTICAL INDUSTRIES LIMITED — Sun Pharma to acquire remaining stake in Taro for $347.73 million

Q What is the typical price range for lenvatinib from India?

Analysis Methodology